Wenqing Yao

Wenqing Yao

Auto-generated profile, based on publicly available information

Wenqing Yao

Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, DE 19803, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
PSPaul Smith
Paul Smith
WYWenqing Yao
Wenqing Yao
SSStacey Shepard
Stacey Shepard
MCMaryanne Covington
Maryanne Covington
JLJames Lee
James Lee
SYSwamy Yeleswaram
Swamy Yeleswaram
Named after the two-faced Roman god of doorways, Janus kinases (JAKs) represent a class of tyrosine kinases. The JAK signaling pathway is pivotal for the downstream signaling of inflammatory cytokines, including interleukins, interferons, and multiple growth factors. This article provides an overview of the JAK pathway and signaling, its significance in immune-mediated dermatologic diseases and the development of a targeted, localized option of a selective JAK inhibitor, ruxolitinib cream. In the early 1990s, various discovery and clinical development programs were initiated to explore pharmaceutical inhibition of the JAK-STAT pathway. Incyte Corporation launched a strategy to identify molecules suitable for both topical as well as oral delivery. Ruxolitinib was designed as a molecule with low nanomolar potency selective for JAK1 and 2 enzymes, but without significant inhibition of non-JAK kinases, as well as physicochemical properties for both topical and oral administration. An oil-in-water emulsified ruxolitinib cream formulation was developed for topical application and was studied in multiple immune-mediated dermatologic diseases including psoriasis, alopecia areata, atopic dermatitis and vitiligo. Ruxolitinib cream represents a novel, JAK1/2 selective therapy that can be delivered directly to the skin to treat a number of cytokine-driven, inflammatory dermatoses.

26 January 2007 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
WYWenqing Yao
Wenqing Yao
JZJincong Zhuo
Jincong Zhuo
DBDavid M. Burns
David M. Burns
MXMeizhong Xu
Meizhong Xu
CZColin Zhang
Colin Zhang
BMBrian Metcalf
Brian Metcalf

7 February 2007 in Synlett
Verified
Journal Article
Closed access
PDF file
JZJincong Zhuo
Jincong Zhuo
WYWenqing Yao
Wenqing Yao
DBDavid Burns
David Burns
CZColin Zhang
Colin Zhang
MXMeizhong Xu
Meizhong Xu
BMBrian Metcalf
Brian Metcalf
An efficient asymmetric synthesis of conformationally constrained (2S,3S)-piperidinedicarboxylic acid derivatives starting from l-aspartic acid β-tert-butyl ester and 3-chloro-2-(chloromethyl)-1-propene is described. The key steps involve N-alkylation of the aspartic acid ester followed by a stereoselective enolate intra­molecular cyclization (>95:5 dr). Various synthetic strategies were explored to achieve the cyclopropanation of the resulting olefin, ­including the Simmons-Smith reaction and palladium-catalyzed cyclopropanation.

1 January 2008 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
WYWenqing Yao
Wenqing Yao
JZJincong Zhuo
Jincong Zhuo
DBDavid M. Burns
David M. Burns
YLYun-Long Li
Yun-Long Li
DQDing-Quan Qian
Ding-Quan Qian
BMBrian Metcalf
Brian Metcalf

10 September 2019
Verified
Conference Paper
Closed access
MPMelissa Parker
Melissa Parker
BFBrittany Fay
Brittany Fay
WYWeqing Yao
Weqing Yao
PSPaul Smith
Paul Smith
Atopic dermatitis (AD) is characterized by intense itch and recurrent eczematous lesions. Interleukin (IL)-33 is constitutively produced from the |

10 September 2019
Verified
Conference Paper
Closed access
MPMelissa Parker
Melissa Parker
BFBrittany Fay
Brittany Fay
MSMonika Scuron
Monika Scuron
EHEduardo Huarte
Eduardo Huarte
RCRobert Collins
Robert Collins
PSPaul Smith
Paul Smith
Allergic contact dermatitis is driven by an overreaction of the body's immune system to a normally harmless substance resulting in skin inflammat |